Skip to main content
PMC home page
Gut logoLink to Gut
. 1992 Jul;33(7):868–871. doi: 10.1136/gut.33.7.868

Role of platelet activating factor on the fibrinolytic activation in the pathogenesis of gastric mucosal damage induced by endothelin-1.

I Kurose 1, S Miura 1, D Fukumura 1, H Tashiro 1, H Imaeda 1, H Shiozaki 1, M Suematsu 1, H Nagata 1, E Sekizuka 1, M Tsuchiya 1
PMCID: PMC1379395  PMID: 1644323

Abstract

We have examined the hypothesis that the release of tissue type plasminogen activator may play a prominent role in endothelin induced gastric mucosal injury. We determined tissue type plasminogen activator activity in the regional blood sample and the concentration of platelet activating factor in the gastric mucosa after the administration of endothelin-1 in a range of 50-500 pmol/kg into the left gastric artery of male Wistar rats. Endothelin-1 increased the tissue type plasminogen activator release and platelet activating factor formation, and induced subsequent gastric mucosal haemorrhagic change in a dose dependent manner. In addition CV-6209, a selective platelet activating factor blocker, attenuated the activation of regional tissue type plasminogen activator and the development of mucosal damage induced by endothelin-1. The results of this study showed that tissue type plasminogen activator activation may play an important role in the pathogenesis of endothelin induced mucosal injury of rat stomach, and suggest that the platelet activating factor may be involved in the process of regional fibrinolytic activation induced by endothelin-1.

Full text

PDF
868

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BLIGH E. G., DYER W. J. A rapid method of total lipid extraction and purification. Can J Biochem Physiol. 1959 Aug;37(8):911–917. doi: 10.1139/o59-099. [DOI] [PubMed] [Google Scholar]
  2. Emeis J. J., Kluft C. PAF-acether-induced release of tissue-type plasminogen activator from vessel walls. Blood. 1985 Jul;66(1):86–91. [PubMed] [Google Scholar]
  3. Korbut R., Lidbury P., Thomas G. R., Vane J. R. Fibrinolytic activity of endothelin-3. Thromb Res. 1989 Sep 15;55(6):797–799. doi: 10.1016/0049-3848(89)90311-3. [DOI] [PubMed] [Google Scholar]
  4. Kurose I., Suematsu M., Miura S., Suzuki M., Nagata H., Morishita T., Sekizuka E., Tsuchiya M. Involvement of superoxide anion and platelet-activating factor in increased tissue-type plasminogen activator during rat gastric microvascular damages. Thromb Res. 1991 May 15;62(4):241–248. doi: 10.1016/0049-3848(91)90145-m. [DOI] [PubMed] [Google Scholar]
  5. Pruis J., Emeis J. J. Endothelin-1 and -3 induce the release of tissue-type plasminogen activator and von Willebrand factor from endothelial cells. Eur J Pharmacol. 1990 Oct 2;187(1):105–112. doi: 10.1016/0014-2999(90)90345-7. [DOI] [PubMed] [Google Scholar]
  6. Rosam A. C., Wallace J. L., Whittle B. J. Potent ulcerogenic actions of platelet-activating factor on the stomach. Nature. 1986 Jan 2;319(6048):54–56. doi: 10.1038/319054a0. [DOI] [PubMed] [Google Scholar]
  7. Rånby M., Norrman B., Wallén P. A sensitive assay for tissue plasminogen activator. Thromb Res. 1982 Sep 15;27(6):743–749. doi: 10.1016/0049-3848(82)90012-3. [DOI] [PubMed] [Google Scholar]
  8. Saldeen T., Ryan J. W., Berryer P. A peptide derived from fibrin(ogen) inhibits angiotensin converting enzyme and potentiates the effects of bradykinin. 1981 Aug 15-Sep 1Thromb Res. 23(4-5):465–470. doi: 10.1016/0049-3848(81)90208-5. [DOI] [PubMed] [Google Scholar]
  9. Suematsu M., Kurose I., Asako H., Miura S., Tsuchiya M. In vivo visualization of oxyradical-dependent photoemission during endothelium-granulocyte interaction in microvascular beds treated with platelet-activating factor. J Biochem. 1989 Aug;106(2):355–360. doi: 10.1093/oxfordjournals.jbchem.a122857. [DOI] [PubMed] [Google Scholar]
  10. Sugatani J., Fujimura K., Miwa M., Mizuno T., Sameshima Y., Saito K. Occurrence of platelet-activating factor (PAF) in normal rat stomach and alteration of PAF level by water immersion stress. FASEB J. 1989 Jan;3(1):65–70. doi: 10.1096/fasebj.3.1.2910739. [DOI] [PubMed] [Google Scholar]
  11. Whittle B. J., Payne A. N., Esplugues J. V. Cardiopulmonary and gastric ulcerogenic actions of endothelin-1 in the guinea pig and rat. J Cardiovasc Pharmacol. 1989;13 (Suppl 5):S103–S123. doi: 10.1097/00005344-198900135-00026. [DOI] [PubMed] [Google Scholar]
  12. Yanagisawa M., Kurihara H., Kimura S., Tomobe Y., Kobayashi M., Mitsui Y., Yazaki Y., Goto K., Masaki T. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature. 1988 Mar 31;332(6163):411–415. doi: 10.1038/332411a0. [DOI] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES